Board Recruitment, Orientation, Training, and Retention
Explain the size, composition, skills, traits and other key assets important to the national kidney foundation . Then identify the strength and weaknesses of the current board composition.
Finally, recommend how this board composition could be changed to improve board performance and organizational effectiveness
Board Composition Analysis | |||||||||||||||||||||||||||||||||||||
| Board Member | GENDER/AGE | RACE/ETHNICITY | QUALITIES | AREA OF EXPERTISE | COMMUNITY CONNECTIONS | ||||||||||||||||||||||||||||||||
| YEARS ON BOARD | Female | Male | 21-35 | 36-50 | 51-65 | Over 65 | Asian/Pacific Islander | Black | Caucasian | Hispanic/Latino | Native American | Other | Leadership | Willingness to work/Availability | Personal Connection with the organizations mission | Good Communicator | Visionary | Strategist | Program | Entrepreneurship | Human Reources | Strategic Planning | Legal | Personnel Administration | Fundraising/Grant Writing | Financial Management | Public Relations | Other | Social Services | Religious Organizations | Medical Support | Media | Access to Money | Other | |||
| Board Member | |||||||||||||||||||||||||||||||||||||
| Art Pasquarella, CRE NKF ChairmanEquus Capital Partners, Ltd | 3 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||||||||||||||
| Michael J. Choi, MD NKF President Nephrology | 3 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||||||||||||||||
| Jeffrey S. Berns, MD NKF Immediate Past President | 4 | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||||||||||||||||
| Michael J. Stevenson, CPA NKF Secretary | 3 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||||||||||||||
| Thomas P. Cassese Director of Business Development | 3 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||||||||||||
| Jim Elkin Chairman & CEO | 3 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||||||||||||||||
| Brennan Hart, Esq | 3 | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||||||||||||||||
| Tom Hough | 3 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||||||||||||||||
| Kailesh Karavadra Managing Partner | 3 | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||||||||||||||||
| Charles Modlin, MD, MBA Kidney Transplant Surgeon and Urologist | 3 | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||||||||||||||||
| Jummy Olabanji Anchor/Reporter | 3 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||||||||||||||
| Stephen Pastan, MD Associate Professor of Medicine | 3 | X | X | X | X | X | X | X | X | X | X | X | |||||||||||||||||||||||||
| Gregory W. Scott | 5 | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||||||||||||||||
| Michael W. Sexton | 3 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||||||||||||||||||
| Stephanie Stewart, LICSW, MBA Operations Administrator | 3 | X | X | X | X | X | X | X | X | X | X | ||||||||||||||||||||||||||
| Anthony Tuggle | 3 | X | X | X | X | X | X | X | X | X | X | X | X | ||||||||||||||||||||||||
| Bradley Warady, MD Pediatric Nephrologist | 3 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||||||||||||||||||